Frailty in Patient Undergoing Percutaneous Left Atrial Appendage Closure.

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorJosep Rodes-Cabau

About this trial

To assess the prevalence and severity of frailty in patients undergoing LAAC, as well as its association to peri-procedural and long-term outcomes and quality of life.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Transcatheter LAAC with any approved device

Age ≥18 years old

Disqualifiers

Unable to provide informed consent

Severe neuropsychiatric impairment

Trial population

Patients ≥18 years old undergoing Transcatheter LAAC with any approved device

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

No trial groups listed

Trial outcomes

Primary outcomes

1

Prevalence of frailty

Evaluated with Clinical Frailty Scale (CFS) 9-point scale (1-Very fit to 9-Terminally ill)

Time frame
Baseline (before transcatheter Left Atrial Appendage Closure)
2

Prevalence of frailty

Evaluated with Essential Frailty Toolset (EFT) (Scored 0 (least frail) to 5 (most frail)

Time frame
Baseline (before transcatheter Left Atrial Appendage Closure)
3

Rate of all-cause mortality

Time frame
1-year follow-up
4

Rate of ischemic events

Stroke

Time frame
1-year follow-up

Secondary outcomes

1

Rate of All-cause mortality

Time frame
2, 3, 4 and 5-year follow-up
2

Rate of ischemic events

Ischemic stroke or peripheral embolism

Time frame
2, 3, 4 and 5-year follow-up
3

Rate of all-cause mortality and ischemic events

Rate of death from any cause + ischemic stroke or peripheral embolism

Time frame
2-, 3-, 4- and 5-year follow-up
4

Rate of Rehospitalisation

Rate of any readmission to a hospital

Time frame
1-, 2-, 3-, 4- and 5-year follow-up

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Josep Rodes-Cabau

Lead sponsor

Institut universitaire de cardiologie et de pneumologie de Québec, University Laval

Sponsor institution